Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease

Clinical trial NCT04352803 · UNKNOWN

Trial details

NCT number: NCT04352803
Sponsor: Regeneris Medical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Covid-19 Pneumonia Cyotokine Storm

Start date: 2020-04-01
Primary completion: 2024-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.